| Next 10 |
Ad
LLY News and Press Eli Lilly and Company
News | Eli Lilly and Company (NYSE:LLY)
-
2024-12-03 14:24:14 ET More on BeiGene BeiGene: Nearing Profitability On TEVIMBRA Approval In The EU And U.S. BeiGene: TEVIMBRA European Push Continues With Positive CHMP Opinion European Commission approves products by BeiGene, GSK and Novartis Indaptus Ther...
-
2024-12-02 23:35:12 ET Summary I track 50 high-quality dividend stocks, updating their valuations daily to identify Strong Buy, Buy, Hold, and Trim opportunities based on historical free cash flow trends. November's performance: Strong Buy portfolio +2.66%, Buy or Better +4.24%, a...
-
2024-12-01 21:12:35 ET Summary This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. It’ll be a busy December for dividend growth investors, with 25 companies announcing their annual inc...
-
2024-11-30 17:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
2024-11-30 06:20:00 ET The market didn't appreciate Amgen 's (NASDAQ: AMGN) latest clinical data update, with the biopharma's shares falling more than 12% at one point on Nov. 26 from the previous day's close, though they recovered to close just 4.7% down for the day. And, with ...
-
2024-11-29 14:16:22 ET Summary US stocks surged post-election, with the S&P 500 up 6% and small caps gaining 11%, driven by optimism and consumer spending. Financials and Consumer Discretionary sectors led gains, while Health Care lagged due to regulatory concerns; Bitcoin soa...
-
2024-11-29 00:50:00 ET Summary The Janus Henderson Global Life Sciences Diversified ADR Managed Account Portfolio returned 5.74% (gross) and the MSCI World Health Care IndexSM returned 5.79%. Positioning in pharmaceuticals weighed on relative returns, while stock selection in biot...
-
2024-11-28 11:40:00 ET Summary The Janus Henderson Forty Fund returned 5.23% and the Russell 1000® Growth Index returned 3.19%. Stock selection in the healthcare and financials sectors contributed to relative performance, while selection in real estate and consumer discretion...
-
2024-11-28 09:14:00 ET Summary US President Joe Biden wants to expand the government’s coverage of weight-loss drugs. If approved by the Trump Administration, this move will increase demand and further reshape the healthcare sector. About 13% of US adults have used a GL...
-
2024-11-28 09:05:00 ET Summary The Janus Henderson Concentrated Growth Managed Account Portfolio returned 4.87% (gross) and the Russell 1000® Growth Index returned 3.19%. Stock selection in the healthcare and financials sectors contributed to relative performance, while selec...
Stock Information
Get LLY Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-11-30 17:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
2024-11-30 06:20:00 ET The market didn't appreciate Amgen 's (NASDAQ: AMGN) latest clinical data update, with the biopharma's shares falling more than 12% at one point on Nov. 26 from the previous day's close, though they recovered to close just 4.7% down for the day. And, with ...
-
2024-11-28 07:30:00 ET Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion. But in recent weeks, its share price has been falling. And now the stock is down over 20% from its 52-week high of $972.53. Could thi...